Back to top

Truist Financial Sticks to Its Buy Rating for Affimed (AFMD)

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Affimed (AFMD – Research Report) today. The company’s shares closed last T...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Affimed N.V. (AFMD)